Baskies Arnold M
SEC Form 4 insider trading activity
Baskies Arnold M has filed 3 SEC Form 4 filings (4 transaction rows) across 1 company, with disclosures dating back to 2026. 3 of those filings fall inside the rolling window. Most recent filing: Sep 28, 2026.
On the most recent filing, Baskies Arnold M is listed as Director at Anixa Biosciences Inc. Inside the rolling window, Baskies Arnold M reported 2 open-market purchases totaling $44K in ANIX and no open-market sales. The largest disclosed transaction in the window is a purchase of 10,000 ANIX shares on Jan 28, 2026, worth $30K.
Companies traded
Other insiders at ANIX
Insider Buying
$44K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Baskies Arnold M made?
Baskies Arnold M has filed 3 SEC Form 4 filings (4 transaction rows) across 1 company since 2026.
Which companies does Baskies Arnold M trade?
Baskies Arnold M has filed SEC Form 4 disclosures for 1 company, including ANIX.
When was Baskies Arnold M's most recent SEC Form 4 filing?
Baskies Arnold M's most recent SEC Form 4 filing on Tracefour is dated Sep 28, 2026.
What is Baskies Arnold M's total buy and sell value in the current window?
Inside the rolling retention window, Baskies Arnold M bought $44K and sold $0 based on SEC Form 4 filings.
What was Baskies Arnold M's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 10,000 ANIX shares on 2026-01-28, worth $30K, per SEC Form 4 filings.